We are a biotechnology company dedicated to developing next-generation therapeutics to improve the lives of patients with severe and life-altering brain diseases. Bright Minds’ broad portfolio of new chemical entities (NCEs) are positioned to treat a variety of pain indications, seizures, and neuropsychiatric disorders.
/image%2F6304363%2F20210212%2Fob_72c5b5_knowledge-biotechnology-company-bright.jpg)
Psychedelics cause a trip that lasts for 5-12 hours. Most people know psychoactive compounds such as Psilocybin as a recreational drug; however, the team of Bright Minds Biosciences has recognized and presented its therapeutic use as well. Our biotechnology...
/image%2F6304363%2F20210128%2Fob_3d6677_psychedelic-treatment.jpg)
Bright Minds is an emerging name in the Biotechnology industry. With the success in Psychedelic treatment and therapies, there is more investor influx for the companies. Once the medical world gets used to the Psychedelic class drugs for their magical...
